Resources from the same session
Refining prognosis in HER2+ early breast cancer (eBC): Insight from biology
Presenter: Aleix Prat
Session: Tailoring treatment for early HER2 breast cancer
Resources:
Slides
Webcast
Neoadjuvant platform as a “risk adapted” strategy
Presenter: Valentina Guarneri
Session: Tailoring treatment for early HER2 breast cancer
Resources:
Slides
Webcast
Early prediction of pathologic response: Where do we stand?
Presenter: Hee Jin Lee
Session: Tailoring treatment for early HER2 breast cancer
Resources:
Slides
Webcast